Gene: BTNL2
Official Full Name: butyrophilin like 2provided by HGNC
Gene Summary: This gene encodes a major histocompatibility complex, class II associated, type I transmembrane protein which belongs to the butyrophilin-like B7 family of immunoregulators. It is thought to be involved in immune surveillance, serving as a negative T-cell regulator by decreasing T-cell proliferation and cytokine release. The encoded protein contains an N-terminal signal peptide, two pairs of immunoglobulin-like domains, separated by a heptad peptide sequence, and a C-terminal transmembrane domain. Naturally occurring mutations in this gene are associated with sarcoidosis, rheumatoid arthritis, ulcerative colitis, inflammatory bowel disease, myositis, type 1 diabetes, systemic lupus erythematosus, acute coronary syndrome, and prostate cancer. [provided by RefSeq, May 2017]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA08391 | BTNL2 Knockout cell line (AC16) | Human | BTNL2 | 1:3-1:4 | negative | Online Inquiry |
| KOA23835 | BTNL2 Knockout cell line (BEAS-2B) | Human | BTNL2 | 1:3~1:4 | negative | Online Inquiry |
| KOA39285 | BTNL2 Knockout cell line (U-2932) | Human | BTNL2 | 1:2-1:4 | negative | Online Inquiry |
| KOA54679 | BTNL2 Knockout cell line (TPC-1) | Human | BTNL2 | 1:5-1:8 | negative | Online Inquiry |
| KOA70090 | BTNL2 Knockout cell line (NCM460) | Human | BTNL2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.